Effect of fenofibrate on apolipoprotein B containing lipoprotein particles.
Fruchart
J C
JC
SERLIA, Institut Pasteur, Lille, France.
Bard
J M
JM
Fievet
C
C
Kandoussi
A
A
Slimane
M
M
Douste-Blazy
P
P
D001055:Apolipoproteins B / Q000097:blood*; D004311:Double-Blind Method; D005260:Female; D011345:Fenofibrate / Q000031:analogs & derivatives / Q000627:therapeutic use*; D006801:Humans; D006938:Hyperlipoproteinemia Type II / Q000097:blood / Q000188:drug therapy*; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D007124:Immunoenzyme Techniques; D008074:Lipoproteins / Q000097:blood*; D008297:Male; D011422:Propionates / Q000627:therapeutic use*; D011897:Random Allocation
D001055:Apolipoproteins B; D000960:Hypolipidemic Agents; D008074:Lipoproteins; D011422:Propionates; C006012:fenofibric acid; D011345:Fenofibrate